Moderna and Merck's melanoma vaccine, combined with Keytruda, could halve cancer recurrence risk, marking a breakthrough in ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

In " Beyond Diagnosis: Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their ...

Researchers say their clinical trial is the first to show that personalized drug treatments based on tumor DNA are safe and ...

New personalized skin cancer treatment shows success in preventing return of high-risk melanoma - Patients with severe ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin ...

Researchers at FIU are advancing a personalized approach to cancer treatment that is showing increasingly promising results ...

Then you have the fact that clinical trials often underrepresent minorities. This can lead to skewed AI models, with 80 ...

Paul Nghiem, MD, PhD, discusses individualized therapies and the evolving role of AI in improving outcomes for actinic keratosis and related skin conditions.

In a major step toward faster and more personalized cancer treatment, scientists have unveiled a powerful AI-driven method that creates custom-designed immune therapies in just weeks. Instead of ...

Scientists are working to develop personalized cancer treatments, but one obstacle in the way is figuring out how different ...

Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...